Matheus Ferracini
Overview
Explore the profile of Matheus Ferracini including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
251
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sahu R, Ferracini M, Travers J
Mediators Inflamm
. 2015 Apr;
2015:820543.
PMID: 25922565
Chemotherapy is used to treat numerous cancers including melanoma. However, its effectiveness in clinical settings is often hampered by various mechanisms. Previous studies have demonstrated that prooxidative stressor-mediated generation of...
2.
Sahu R, Ocana J, Harrison K, Ferracini M, Touloukian C, Al-Hassani M, et al.
Cancer Res
. 2014 Oct;
74(23):7069-78.
PMID: 25304264
Oxidative stress suppresses host immunity by generating oxidized lipid agonists of the platelet-activating factor receptor (PAF-R). Because many classical chemotherapeutic drugs induce reactive oxygen species (ROS), we investigated whether these...
3.
Ferracini M, Sahu R, Harrison K, Waeiss R, Murphy R, Jancar S, et al.
J Invest Dermatol
. 2014 Jul;
135(1):321-323.
PMID: 25050596
No abstract available.
4.
Ferracini M, Rios F, Pecenin M, Jancar S
Mediators Inflamm
. 2013 Dec;
2013:950273.
PMID: 24347838
Phagocytosis of apoptotic cells (efferocytosis) induces macrophage differentiation towards a regulatory phenotype (IL-10(high)/IL-12p40(low)). CD36 is involved in the recognition of apoptotic cells (AC), and we have shown that the platelet-activating...
5.
Rios F, Ferracini M, Pecenin M, Koga M, Wang Y, Ketelhuth D, et al.
PLoS One
. 2013 Oct;
8(10):e76893.
PMID: 24130805
Macrophage interaction with oxidized low-density lipoprotein (oxLDL) leads to its differentiation into foam cells and cytokine production, contributing to atherosclerosis development. In a previous study, we showed that CD36 and...
6.
Rios F, Koga M, Pecenin M, Ferracini M, Gidlund M, Jancar S
Mediators Inflamm
. 2013 Sep;
2013:198193.
PMID: 24062612
OxLDL is recognized by macrophage scavenger receptors, including CD36; we have recently found that Platelet-Activating Factor Receptor (PAFR) is also involved. Since PAFR in macrophages is associated with suppressor function,...
7.
Rios F, Koga M, Ferracini M, Jancar S
PLoS One
. 2012 May;
7(5):e36632.
PMID: 22570732
The oxidative process of LDL particles generates molecules which are structurally similar to platelet-activating factor (PAF), and some effects of oxidized LDL (oxLDL) have been shown to be dependent on...
8.
Ferracini M, Martins J, Campos M, Anger D, Jancar S
Mol Immunol
. 2010 Jun;
47(11-12):1974-80.
PMID: 20510456
Diabetic individuals are more susceptible to infections and this seems to be related to impaired phagocyte function. Alveolar macrophages (AMs) are the first barrier to prevent respiratory infections. Leukotrienes (LTs)...
9.
Martins J, Ferracini M, Anger D, Martins D, Ribeiro Jr L, Sannomiya P, et al.
Shock
. 2009 Apr;
33(1):76-82.
PMID: 19373130
Diabetic patients are more susceptible to infections, and their inflammatory response is impaired. This is restored by insulin treatment. In the present study, we investigated the effect of insulin on...
10.
Martins J, Ferracini M, Ravanelli N, Landgraf R, Jancar S
Cell Physiol Biochem
. 2008 Sep;
22(1-4):279-86.
PMID: 18769055
The development of septic shock is a common and frequently lethal consequence of gram-negative infection. Mediators released by lung macrophages activated by bacterial products such as lipopolysaccharide (LPS) contribute to...